Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2017; 117(05): 829
DOI: 10.1160/TH17-03-0167
DOI: 10.1160/TH17-03-0167
T&H Insight
High on treatment platelet reactivity as a risk factor for adverse left ventricular remodelling after STEMI
Further Information
Publication History
Received:
10 March 2017
Accepted:
10 March 2017
Publication Date:
28 November 2017 (online)
Insight on: Park et al. Thromb Haemost 2017; 117: 911-922.
-
References
- 1 Cattaneo M. High on-treatment platelet reactivity--definition and measurement. Thromb Haemost 2013; 109: 792-798.
- 2 Westman PC, Lipinski MJ, Luger D. et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol 2016; 67: 2050-2060.
- 3 Park Y, Tantry US, Koh J-S. et al. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial. Thromb Haemost 2017; 117: 911-922.
- 4 Cattaneo M. P2Y12 receptors: structure and function. J Thromb Haemost 2015; 13 (Suppl. 01) S10-16.